The current valuation score of Rhythm Pharmaceuticals Inc is 9.46, ranking 18 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -30.86, which is -84.36% below the recent high of -4.83 and -22.98% above the recent low of -37.96.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.